Course Title: Managing Co-Morbidities Associated with Psoriasis and Care Improvement Strategy
Date of Original Release: July 12, 2021
Date of Expiration: July 12, 2024
Estimated Time of Completion: 30 minutes
Target Audience
Dermatologists and others involved in the delivery of dermatologic care.
Statement of Need
The American Academy of Dermatology bases its CME activities on identified professional practice gaps, the educational needs which underlie these gaps, and emerging clinical research findings as these relate to dermatology. Learners should reflect upon clinical and scientific information presented in this CME activity and determine the need for further study.
Learning Objectives
Following participation in this activity, the learner should be able to:
- Discuss the prevalence and association of various co-morbid conditions in psoriasis.
- Improve awareness among patients on associated co-morbid conditions.
- Design a preventive therapy by routine screening for signs and symptoms of various co-morbid conditions
- Recognize known gaps and barriers to screening psoriatic patients for comorbidities.
- Perform routine screening for signs/symptoms on various co-morbidities and make appropriate referrals for management.
- Identify performance indicators, associated tools, and resources which aid in the assessment and improvement of the quality of addressing comorbidities with psoriasis.
Accreditation Statement
The American Academy of Dermatology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA PRA Credit Statement
The American Academy of Dermatology designates this Enduring material for a maximum of .5 AMA PRA Category 1 CreditTM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Instructions to Claim Credit
To Claim CME credit for this activity, the learner must complete the post-activity evaluation survey.
Planners:
Vidhya Hariharan, PhD – Senior Manager, Clinical Practice Guidelines Research
American Academy of Dermatology
Rosemont, IL
Sameer Malik, MD, MBA – Associate Director, Science & Clinical Guidance
American Academy of Dermatology
Rosemont, IL
Laura Vera, LSW – Associate Director, Quality Innovation
American Academy of Dermatology
Rosemont, IL
Speakers:
Dawn Davis, MD, FAAD
Professor, Department of Dermatology
Mayo Clinic
Rochester, Minnesota
Sylvia Parra, MD, FAAD
Dermatologist, Dermatology and Skin Surgery
Sumpter, South Carolina
Reviewers:
Vidhya Hariharan, PhD – Senior Manager, Clinical Practice Guidelines Research
American Academy of Dermatology | Association
Rosemont, IL
Mona El-Shamaa, MPH – Program Manager, Quality Improvement
American Academy of Dermatology | Association
Rosemont, IL
Staff:
Christine Presta – Associate Director, Digital Learning
American Academy of Dermatology
Rosemont, IL
Andrew Theisen- Manager, Digital Learning
American Academy of Dermatology
Rosemont, IL
Christina Cortese – Senior Instructional Designer
American Academy of Dermatology
Rosemont, IL
Melinda Keske – Coordinator, Digital Learning
American Academy of Dermatology
Rosemont, IL
Disclosures
All planners, speakers, reviewers, and staff for this activity have no relevant financial relationships with ineligible companies (formerly known as commercial interests).
Conflict Mitigation Statement
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, the American Academy of Dermatology has implemented mechanisms, prior to the planning implementation of this activity, to identify and mitigate conflicts of interest for all individuals in a position to control the content.
Unapproved Use Disclosure
The American Academy of Dermatology requires CME faculty/authors to disclose to learners when products or procedures are being discussed are off-label (not approved for the indications being discussed), unlabeled (not approved for any indications), experimental and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. This information is intended solely for continuing medical education and is not intended to promote off-label use of these products/procedures. If you have questions, contact the medical affairs department of the manufacturer for the most recent approval information. Faculty/authors of this activity may be discussing information about pharmaceutical agents that is outside of the U.S. Food and Drug Administration approved labeling.
Disclaimer
The American Academy of Dermatology (AAD) is not responsible for statements made by the author(s). Statement or opinions expressed in this activity reflect the views of the author(s) and do not reflect the official policy of the AAD. The information provided in this CME activity is for continuing education purposes only, is not intended to establish a standard of care, and is not meant to substitute for independent medical judgment of a health provider relative to the diagnostic, management and treatment options of a specific patient’s medical condition.
No Medical Advice
The information in this publication by the American Academy of Dermatology or any third party should not be considered medical advice and is not intended to replace consultation with a qualified dermatology professional. The American Academy of Dermatology does not answer specific medical questions or refer people to a particular dermatology professional.
Contact Information
For the American Academy of Dermatology Member Resource Center, please call (866) 503-7546.